Expertise in
4
conditions

Rieke N. Fischer

Kerpener Str. 62, 
Koeln, NW, DE 
Expertise in
4
conditions
Kerpener Str. 62, 
Koeln, NW, DE 

Overview

Rieke Fischer practices practicing medicine in Koeln, Germany.

Fischer is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Duchenne Muscular Dystrophy, and Becker Muscular Dystrophy.

They are actively involved in clinical research, co-authoring 198 peer reviewed articles and participating in 1 clinical trial.

Locations

Kerpener Str. 62, Koeln, NW 50931, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase II Trial to Evaluate Efficacy and Safety of Erdafitinib in Patients With Advanced Non Small Cell Lung Carcinoma (NSCLC) Harboring Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations After Relapse of Standard Therapy.
A Phase II Trial to Evaluate Efficacy and Safety of Erdafitinib in Patients With Advanced Non Small Cell Lung Carcinoma (NSCLC) Harboring Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations After Relapse of Standard Therapy.
Enrollment Status: Terminated
Publish Date: June 09, 2023
Intervention Type: Drug
Study Drug: Erdafitinib
Study Phase: Phase 2

198 Total Publications

Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations to assess therapeutic responses.
Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations to assess therapeutic responses.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 12, 2026

Frequently Asked Questions about Rieke N. Fischer

Is Rieke N. Fischer a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Rieke N. Fischer is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Rieke N. Fischer participate in research or clinical trials?

Yes. Rieke N. Fischer has published 198 articles and abstracts on conditions like Lung Cancer. You can view a list of Rieke N. Fischer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Fischer's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile